MTOR and neoplasm: Immunohistochemistry (IHC) of tumor specimens showed a visible decrease in the expression of Ki67, RSK, p70S6K, mTOR, p-mTOR and N-cadherin (N-Cad), and the E-cadherin (E-Cad) expression was increased compared with control (Figure 6H).